Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 195-199
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.195
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.195
Table 1 Analysis of T cells phenotypes of PBMCs from healthy controls and HCC patients (Mean ± SD)
| Groups | n | CD4 | CD8 | CD3 | CD3/CD25 | CD4/CD8 |
| Normal control | 22 | 34.74 ± 6.19 | 28.70 ± 5.11 | 66.56 ± 10.24 | 1.22 ± 0.13 | 1.20 ± 0.18 |
| HCC | 19 | 31.40 ± 4.70 | 25.83 ± 3.98 | 61.30 ± 4.61 | 1.22 ± 0.12 | 1.26 ± 0.17 |
| P value | 0.058 | 0.051 | 0.038 | 0.918 | 0.279 |
- Citation: Wan YL, Zheng SS, Zhao ZC, Li MW, Jia CK, Zhang H. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World J Gastroenterol 2004; 10(2): 195-199
- URL: https://www.wjgnet.com/1007-9327/full/v10/i2/195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i2.195